Home
>
Isotope Labeled Compounds>Isotope Labeled Inhibitors>
>
(R)-3-Hydroxybutanoic acid-13C2 sodium
For research use only. Not for therapeutic Use.
(R)-3-Hydroxybutanoic acid-13C2 sodium (CAS: 202114-54-3), a premium pharmaceutical research compound designed for advanced metabolic and biochemical studies. This isotopically labeled compound offers enhanced stability and precise tracking in metabolic pathways. (R)-3-Hydroxybutanoic acid-13C2 sodium is ideal for use in pharmacological and biochemical research, providing accurate and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel metabolic therapies. Trusted by leading laboratories, (R)-3-Hydroxybutanoic acid-13C2 sodium is your go-to solution for cutting-edge research. Unlock new possibilities in metabolic studies with (R)-3-Hydroxybutanoic acid-13C2 sodium, where innovation meets reliability.
Catalog Number | S000245 |
CAS Number | 202114-54-3 |
Molecular Formula | C213C2H7NaO3 |
Purity | ≥95% |
InChI | InChI=1S/C4H8O3.Na/c1-3(5)2-4(6)7;/h3,5H,2H2,1H3,(H,6,7);/t3-;/m1./s1/i1+1,2+1; |
InChIKey | CWQQGENZHRKCMJ-WGJKDMNVSA-N |
SMILES | [13CH3][C@H]([13CH2]C(=O)O)O.[Na] |
Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [2]. Ide T. Enzymatic-HPLC method to analyze D-3-hydroxybutyric acid in rat serum. Biosci Biotechnol Biochem. 2010;74(8):1578-82. [3]. Mateusz Biernacki, et al. Production of (R)-3-hydroxybutyric acid by Arxula adeninivorans. AMB Express. 2017 Dec;7(1):4. |